Based on the hypothesis that melanoma spreads stepwise from the primar
y tumour to the regional lymph nodes and thereafter to distant sites,
it is suggested that elective lymph node dissection (ELND) in head and
neck melanoma can remove microscopic disease and thereby improve surv
ival. Although from a theoretical point of view this represents an att
ractive theory, there is still no consensus about the beneficial role
of ELND. So far, retrospective studies present conflicting evidence an
d it is hypothesized that only a subgroup of patients may have surviva
l benefit from this procedure. The primary melanoma harbours the most
significant prognostic indicators, among which the tumour thickness is
of utmost importance. Since patients with an intermediate thickness m
elanoma(Breslow 1.51-4 mm) probably have a higher risk of developing l
ymphatic metastases than distant metastases. this subgroup of patients
may have survival benefit from additional regional surgery. ELND is n
ot indicated in thin melanomas as they have a favourable outcome, and
thick melanomas are excluded because of the high risk of distant disea
se at the time of presentation. Elective procedures for primary lesion
s of the face, anterior scalp and ear may be limited to dissection of
levels I through IV, including a parotidectomy. For posterior lesions
sparing of level I may be justified. Advanced radiological diagnostic
techniques may reduce the number of patients who will be potential can
didates for ELND. Further refinements in the diagnosis of occult neck
node metastases may emerge from intraoperative biopsy of the sentinel
node for primary melanomas of the neck and posterior scalp. New multic
entric randomized surgical trials involving ELND are still warranted,
however, for a reduced number of patients because of the more exact in
clusion criteria on staging of the neck and on the main prognostic ind
icators.